Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Salvage Therapy With Idarubicin in Relapsing CNS Lymphoma

This study has been terminated.
(due to slow accrual)
Information provided by:
International Extranodal Lymphoma Study Group (IELSG) Identifier:
First received: September 13, 2005
Last updated: July 29, 2010
Last verified: July 2010
No Study Results Posted on for this Study
  Study Status: This study has been terminated.
  Estimated Study Completion Date: No date given
  Primary Completion Date: July 2010 (Final data collection date for primary outcome measure)